Accessibility Statement Skip Navigation
  • Resources
  • Blog
  • Journalists
  • +44 (0)20 7454 5110
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All Public Company News
      • All Multimedia News
      • View All News Releases

      • Regulatory News

      • D/A/CH Regulatory News
      • UK Regulatory News
      • View All Regulatory News

  • Business & Money
      • Auto & Transportation

      • Aerospace & Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads & Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking & Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers & Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalisation
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls & Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil & Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defence
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation & Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking & Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers & Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines & Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics & Personal Care
      • Fashion
      • Food & Beverages
      • Furniture & Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewellery
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film & Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks & Tourist Attractions
      • Gambling & Casinos
      • Hotels & Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Animal Welfare
      • Corporate Social Responsibility
      • Economic News, Trends & Analysis
      • Education
      • Environmental
      • European Government
      • Labour & Union
      • Natural Disasters
      • Not For Profit
      • Public Safety
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • SocialBoost
  • Rooms
    • MediaRoom
    • ESG Rooms
  • AI Tools
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Hamburger menu
  • Cision PR Newswire UK provides press release distribution, targeting, monitoring, and marketing services
  • Send a Release
    • Phone

    • +44 (0)20 7454 5110 from 8 AM - 5:30 PM GMT

    • ALL CONTACT INFO
    • Contact Us

      +44 (0)20 7454 5110
      from 8 AM - 5:30 PM GMT

  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • News in Focus
    • Browse News Releases
    • Regulatory News
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
    • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • Overview
  • Distribution
  • Paid Placement
  • Multimedia
  • Disclosure Services
  • Cision Communications Cloud®
  • AI Tools
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists
  • General Enquiries
  • Media Enquiries
  • Partnerships
  • Client Login
  • Send a Release
  • Resources
  • Blog
  • Journalists

Vaccines Market Size To Reach USD 153.49 Billion, With at a 14.1% CAGR between 2022 to 2028 | Brandessence Market Research

This image opens in the lightbox

News provided by

Brandessence Market Research And Consulting Private Limited

26 Sep, 2023, 06:48 GMT

Share this article

Share toX

Share this article

Share toX

LONDON, Sept. 26, 2023 /PRNewswire/ -- According to a comprehensive research report by Brandessence Market Research (BMRC), "Vaccines Market Size, Share, Companies & Trends Analysis Report By Technology, By Indication, By End User, Based On Region, And Segment Forecasts, 2022-2028". The Vaccines Market was valued at USD 56.98 billion in 2021 and expected to reach USD 153.49 billion By 2028, amplifying with a CAGR of 14.1% over 2022-2028.

Market Overview:

In a world that has been irrevocably altered by the COVID-19 pandemic, the vaccines market has come into sharper focus than ever before. With the race to develop effective vaccines against the virus, the industry has witnessed unprecedented growth and innovation. However, the vaccines industry is not limited to just one virus; it encompasses a wide range of vaccines designed to combat various diseases. In this article, we will delve into the market, exploring its scope, segmentation, market dynamics, and its promising outlook.

Scope of the Vaccines Market:

Report Metric

Details

Vaccines Market Revenue forecast in 2028

USD 153.49 billion

Market Size in 2021

USD 56.98 billion

Market Growth Rate

CAGR of 14.1% from 2022 to 2028

Base Year

2021

Study Period

2022-2028

Key Players/Companies

Glaxo Smith Kline plc, Pfizer Inc., Merck & Co. Inc., Sanofi, CSL Limited, Emergent BioSolutions Inc., Johnson & Johnson, Medimmune LLC, AstellasPharma Inc., Serum Institute of India, Bavarian Nordic, Mitsubishi Tanabe Pharma Corporation, Daiichi Sankyo Company Limited, Panacea Biotech, Protein Sciences Corporation, AstraZeneca, Abbott, Bristol-Myers Squibb, Novavax Inc., Gritstone Oncology, PaxVax Corporation., Bharat Biotech., VBI Vaccines Inc., Dynavax Technologies Corporation, Immunomic Therapeutics Inc., Gamma Vaccines Pty Limited, Sinovac Biotech Ltd., Janssen Pharmaceutical Company, Takeda Pharmaceuticals Company Ltd., Valeant Pharmaceuticals International Inc., China National Biotech, Tiantan, Hualan, Kangtai, Prokarium, ImmunoBiology Ltd.

The scope of the vaccines market is vast, covering a plethora of infectious diseases and preventive measures. Vaccines are biological products that stimulate the immune system to produce an immune response against specific pathogens. This market extends its reach to vaccines targeting diseases such as influenza, hepatitis, polio, measles, mumps, rubella, and more. Additionally, the recent surge in vaccine development for emerging diseases like COVID-19 has showcased the industry's capacity for rapid response.

Moreover, the vaccines market has witnessed an expansion into therapeutic vaccines, which hold the potential to treat diseases like cancer and autoimmune disorders. The market's scope, therefore, is not just limited to prevention but also includes treatment, making it a crucial segment of the pharmaceutical and healthcare sectors.

Get Free Sample PDF Brochure:

https://brandessenceresearch.com/downloadSample/PostId/276

Segmentation of the Vaccines Market:

The market can be segmented in various ways to provide a comprehensive view of its dynamics. Here are some key segments:

1. Type of Vaccine:

  • Inactivated Vaccines: These contain killed pathogens or portions of them, incapable of causing disease.
  • Live Attenuated Vaccines: These contain weakened forms of the pathogen, which can still induce an immune response without causing the disease.
  • Subunit, Recombinant, or Conjugate Vaccines: These vaccines contain only specific antigens or proteins from the pathogen.
  • mRNA Vaccines: A more recent addition, these vaccines use genetic material to trigger an immune response.

2. Disease Indication:

  • Infectious Diseases: This includes vaccines against viral and bacterial infections.
  • Non-Infectious Diseases: This encompasses therapeutic vaccines against cancer, allergies, and autoimmune disorders.

3. Age Group:

  • Pediatric Vaccines: Designed for infants and children to protect against childhood diseases.
  • Adult Vaccines: Targeting diseases such as influenza, shingles, and HPV in adults.

4. Region:

  • North America, Europe, Asia-Pacific, and Rest of the World: Each region has its own vaccine market dynamics influenced by factors like disease prevalence, healthcare infrastructure, and government policies.

Browse In-depth Market Research Report (300 Pages) on Vaccines Market:

https://brandessenceresearch.com/healthcare/vaccines-market-by-technology

Competitive Hierarchy:

The prominent players Vaccines Market Outlook are-

  • Glaxo Smith Kline plc
  • Pfizer Inc.
  • Merck & Co. Inc.
  • Sanofi
  • CSL Limited
  • Emergent BioSolutions Inc.
  • Johnson & Johnson
  • Medimmune LLC
  • AstellasPharma Inc.
  • Serum Institute of India
  • Bavarian Nordic
  • Mitsubishi Tanabe Pharma Corporation
  • Daiichi Sankyo Company Limited
  • Panacea Biotech
  • Protein Sciences Corporation
  • AstraZeneca
  • Abbott
  • Bristol-Myers Squibb
  • Novavax Inc.
  • Gritstone Oncology
  • PaxVax Corporation.
  • Bharat Biotech.
  • Others.

Market Dynamics:

1. Growing Awareness and Immunization Campaigns

The global awareness of the importance of vaccination has surged, driven by educational campaigns and increasing access to information. Governments and healthcare organizations worldwide are running immunization programs to reach underserved populations, contributing to market growth.

2. Expanding Investment in Research and Development

The COVID-19 pandemic has highlighted the need for rapid vaccine development. This has led to increased investment in research and development, fostering innovation in vaccine technology.

3. Rising Disease Burden

As global populations grow and age, the burden of infectious and non-infectious diseases is on the rise. This necessitates the development of new and improved vaccines.

4. Regulatory Support and Stringent Quality Control

Governments and regulatory bodies play a pivotal role in ensuring vaccine safety and efficacy. Stringent quality control measures are in place to maintain public trust.

Purchase Copy of This Research Report @:

https://brandessenceresearch.com/Checkout?report_id=276

Vaccines Market Outlook:

The future of the vaccines market is bright. It is expected to continue its growth trajectory due to ongoing research and development efforts, increased disease awareness, and government support. The global vaccine market is also likely to benefit from advancements in vaccine technology, including mRNA vaccines and personalized vaccines tailored to individual genetic profiles.

Additionally, the lessons learned from the rapid development of COVID-19 vaccines have paved the way for a more agile and responsive industry, better prepared to tackle emerging threats. With a broader range of preventive and therapeutic vaccines on the horizon, the market is poised to play a pivotal role in shaping the future of healthcare.

Conclusion:

The vaccines market is not just about preventing diseases; it is about safeguarding public health and driving innovation in healthcare. As we navigate the challenges of an ever-evolving healthcare landscape, the vaccines market will remain at the forefront, offering hope, protection, and a brighter future for humanity.

Related Reports:

Demodex Blepharitis: How to Achieve Eye Health and Eliminate Demodex

Navigating Solid Tumor Diseases: Insights and Consulting Services

Unveiling Hope: Navigating Duchenne Muscular Dystrophy (DMD)

Unlocking Relief: Effective Psoriasis Disease Management Strategies

Unlocking the Latest Breakthroughs in Alzheimer's Disease Research: Hope on the Horizon

Rising Against the Odds: Global Insights into Multiple System Atrophy (MSA) Disease

Case study on the Development of Innovative Medicine

Case Study: Software Application for Personalized Care with Data-Driven Insights

Case Study: Cancer Vaccine with Specific Antigens

Combination Trials for Lung Cancer Immunotherapy - Case Study

Using software to manage the supply chain and the inventory

Asset Scouting for Cystic Fibrosis: A Case Study

A Revolutionary Non-Invasive Glucose Monitoring Device Receives Regulatory Approval and Effective Commercialization

Investment in Pancreatic Cancer Chemotherapy

Predictive Analytics Powered by AI: Unlocking Insights for the Future of Healthcare

Natural Language Processing (NLP) in Healthcare: Unlocking the Potential

Posluma: A Targeted Oncology Breakthrough in Prostate Cancer Imaging

Fezolinetant by Veozah: Advancing Women's Health by Astellas Pharma Inc.

A Hopeful Sign for Migraine Sufferers: Zavzpret

Rethinking Treatment Options for a Better Future with Hemophilia Gene Therapy

About Us:

Brandessence Market Research & Consulting Pvt ltd.

Brandessence Market Research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Follow Us: LinkedIn  

Contact:

Mr. Vishal Sawant 
Email: vishal@brandessenceresearch.com
Email: Sales@brandessenceresearch.com 
Corporate Sales: +44-2038074155 
Asia Office: +917447409162

Logo: https://mma.prnewswire.com/media/1392316/BEMR_Logo.jpg

Modal title

Contact PR Newswire

  • +44 (0)20 7454 5110
    from 8 AM - 5:30 PM GMT
  • General Enquiries
  • Media Enquiries
  • Partnerships

Products

  • Content Distribution
  • Multimedia Services
  • Disclosure Services
  • Cision Communications Cloud®

About

  • About PR Newswire
  • About Cision
  • Partnering Opportunities
  • Careers
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United States
  • Vietnam

My Services

  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
  • Data Privacy

Do not sell or share my personal information:

  • Submit via Privacy@cision.com 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Customer Portal
  • Resources
  • Blog
  • Journalists
+44 (0)20 7454 5110
from 8 AM - 5:30 PM GMT
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 PR Newswire Europe Limited. All Rights Reserved. A Cision company.